Laboratory of Cellular Pharmacology of Arteriosclerosis - Associated unit of experimental pathology in the field of the metabolic diseases
Understanding the role of proprotein convertase subtilisin/kexin tupe 9 (PCSK9) beyond lipid lowering effect: focus on inflammation
Relationship between endocrine disorders (hypogonadism) and cardiovascular diseases
Impact of air pollution exposure on cardiovascular diseases: focus on PCSK9
Understanding mitochondrial activity in adipogenesis
In vitro models: gene and protein expression (qPCR and western blot analyses, respectively), immunofluorescence analysis, cell proliferation and migration assays, cell cytotoxicity assay, Oil red O staining and extraction, FACS-based analysis, mitochondrial function assay (“Seahorse XF” technology, measurement of citrate synthase activity, mtDNA analysis, measurement of mitochondrial mass and transmembrane potential), evaluation of intracellular signaling pathways.
In vivo models: Manipulation of murine models, including use of specific dietary patterns (high-fat diet) related to metabolic diseases and obesity, as well as peripheral blood (intraperitoneal glucose, insulin or pyruvate tolerance test, fast-refeed assay) and tissue sampling and related molecular analyses, mitochondria isolation and subsequent analyses, extraction of mouse embryonic fibroblasts, isolation of live, motile sperm from mice, mice breeding.
Prof. Nicola Ferri; Prof. Maciej Banach; Professor Carsten Culmsee; Prof.ssa Laura Calabresi; Prof. Franco Bernini; Prof. Danilo Giuseppe Norata; Prof.ssa Valentina Bollati; Prof. Luca Valenti; Prof.ssa Elena Marcello and Dott. Marco Bonomi.
High density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. Adorni MP, Zimetti F, Cangiano B, Vezzoli V, Bernini F, Caruso D, Corsini A, Sirtori CR, Cariboni A, Bonomi M, Ruscica M. J Clin Endocrinol Metab. 2019 Mar 5. pii: jc.2018-02027. doi: 10.1210/jc.2018-02027.
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals. Macchi C, Ferri N, Favero C, Cantone L, Vigna L, Pesatori AC, Lupo MG, Sirtori CR, Corsini A, Bollati V, Ruscica M.. Eur J Prev Cardiol. 2018 Nov 26:2047487318815320. doi: 10.1177/2047487318815320.
PCSK9 induces a pro-inflammatory response in macrophages. Ricci C, Ruscica M, Camera M, Rossetti L, Macchi C, Colciago A, Zanotti I, Lupo MG, Adorni MP, Cicero AFG, Fogacci F, Corsini A, Ferri N. Sci Rep. 2018 Feb 2;8(1):2267. doi: 10.1038/s41598-018-20425-x.
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders. Ruscica M, Simonelli S, Botta M, Ossoli A, Lupo MG, Magni P, Corsini A, Arca M, Pisciotta L, Veglia F, Franceschini G, Ferri N, Calabresi L. Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):991-997.
Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line. Ruscica M, Ricci C, Macchi C, Magni P, Cristofani R, Liu J, Corsini A, Ferri N. J Biol Chem. 2016 Feb 12;291(7):3508-19.